Acer Therapeutics Announces Agreement with FDA on Special Protocol Assessment for its Phase 3 EDSIVO™ (celiprolol) Trial in Vascular Ehlers-Danlos Syndrome PatientsPhase 3 DiSCOVER clinical trial initiation expected by end of Q2 2022 – BioSpace
05/09/2022
Acer Therapeutics Announces Agreement with FDA on Special Protocol Assessment for its Phase 3 EDSIVO™ (celiprolol) Trial in Vascular Ehlers-Danlos Syndrome PatientsPhase 3 DiSCOVER clinical trial initiation expected by end of Q2 2022  BioSpace

VBI VACCINES INC/BC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
05/09/2022
VBI VACCINES INC/BC Management’s Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)  Marketscreener.com

Kevin Steele adds Mike Fasano's endorsement to HD 55 support – Florida Politics
05/09/2022
Kevin Steele adds Mike Fasano’s endorsement to HD 55 support  Florida Politics